Delivery Order SPE2DB24D2205-SPE2DB25FEGQQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,361.69 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order, awarded on July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $2,726.70 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $8,508.28 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,479.02 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order executed on August 14, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,088.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $2,421.44, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $19,570.26 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a $2,317.23 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $11,587.73 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGQQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,363.52 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This competitive award uses firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables the supply of a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. This delivery order for topical pain management medication reflects the company's ongoing role in fulfilling pharmaceutical supply requirements across the Defense Health System, with no set-aside designation applied to the award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/22/25 |